There is abundant evidence that overexpression of CCL2 promotes tumor metastasis, invasion, and immune resistance; however, some findings indicate that CCL2 expression can also initiate infiltration of anti-tumor inflammatory monocytes (1). Here, CCL2 is linked to neoplasm.